0268-0878 : Cochliobolus Sativus 20000 [pnu]/Ml Subcutaneous Injection, Solution


NDC: 0268-0878
Labeler: Alk-abello, Inc.
Product Type: Non-standardized Allergenic
Drug Name: Cochliobolus Sativus
Dosage Form: Subcutaneous Injection, Solution
Application #: BLA103753
Rev. Date: 


NDC Package Codes:

  • 0268-0878-10: 10 ML IN 1 VIAL, MULTI‑DOSE (0268‑0878‑10)
  • 0268-0878-50: 50 ML IN 1 VIAL, MULTI‑DOSE (0268‑0878‑50)

Active Ingredients:

  • Cochliobolus Sativus

Dosage Strength:

  • 20000 [PNU]/mL

Pharmaceutical Classes:

  • Non-Standardized Fungal Allergenic Extract [EPC]
  • Increased Histamine Release [PE]
  • Cell-mediated Immunity [PE]
  • Increased IgG Production [PE]
  • Fungal Proteins [Chemical/Ingredient]
  • Allergens [Chemical/Ingredient]

Related Products:

Based on records with the same trade name.
  • 0268-0879 Cochliobolus Sativus 40000 [pnu]/Ml Subcutaneous Injection, Solution by Alk-abello, Inc.
  • 0268-0880 Cochliobolus Sativus 10000 [pnu]/Ml Subcutaneous Injection, Solution by Alk-abello, Inc.
  • 0268-0881 Cochliobolus Sativus .001 g/ml Subcutaneous Injection, Solution by Alk-abello, Inc.
  • 0268-0882 Cochliobolus Sativus 20000 [pnu]/Ml Subcutaneous Injection, Solution by Alk-abello, Inc.
  • 0268-0883 Cochliobolus Sativus 10000 [pnu]/Ml Subcutaneous Injection, Solution by Alk-abello, Inc.
  • 0268-6524 Cochliobolus Sativus .1 g/ml Percutaneous Injection, Solution by Alk-abello, Inc.
  • 0268-6525 Cochliobolus Sativus 1000 [pnu]/Ml Intradermal Injection, Solution by Alk-abello, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0268-0878 QR Code

< Prev: 0268-0871Next: 0268-0879 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.